Retreatment with the induction regimen in small cell lung cancer relapsing after an initial response to short term chemotherapy

Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell line.

Jan G. Zijlstra, Elisabeth G.E. de Vries, Nanno H. Mulder · PubMed · 1987 · 264 citations

Medicine, Molecular Biology, Oncology +17

Etoposide (VP-16) and cisplatin: an effective treatment for relapse in small-cell lung cancer.

William K. Evans, David Osoba, Ronald Feld et al. · Journal of Clinical Oncology · 1985 · 191 citations

Medicine, Oncology, Pharmacology +14

Teniposide (VM-26), an overlooked highly active agent in small-cell lung cancer. Results of a phase II trial in untreated patients.

E Bork, M Hansen, P Dombernowsky et al. · Journal of Clinical Oncology · 1986 · 73 citations

Pharmacy, Oncology, Pharmacotherapy +15

Small-Cell Carcinoma of Lung: Reinduction Therapy After Late Relapse

Gerald Batist · Annals of Internal Medicine · 1983 · 71 citations

Medicine, Oncology, Pharmacotherapy +15

Etoposide (VP-16) and cisplatin in previously treated small-cell lung cancer: clinical trial and in vitro correlates.

Gerald Batist, D N Carney, Kenneth H. Cowan et al. · Journal of Clinical Oncology · 1986 · 37 citations

Medicine, Oncology, Pharmacology +13